185 related articles for article (PubMed ID: 12361758)
1. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
[TBL] [Abstract][Full Text] [Related]
2. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
[TBL] [Abstract][Full Text] [Related]
3. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
4. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
Sun X; Chen W; He L; Sheng J; Liu Y; Vu GP; Yang Z; Li W; Trang P; Wang Y; Hai R; Zhu H; Lu S; Liu F
PLoS One; 2017; 12(10):e0186791. PubMed ID: 29059242
[TBL] [Abstract][Full Text] [Related]
6. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
Trang P; Kim K; Zhu J; Liu F
J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
[TBL] [Abstract][Full Text] [Related]
7. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture.
Kilani AF; Trang P; Jo S; Hsu A; Kim J; Nepomuceno E; Liou K; Liu F
J Biol Chem; 2000 Apr; 275(14):10611-22. PubMed ID: 10744757
[TBL] [Abstract][Full Text] [Related]
8. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
Trang P; Kim K; Liu F
Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
[TBL] [Abstract][Full Text] [Related]
9. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
[TBL] [Abstract][Full Text] [Related]
10. Engineered external guide sequences are highly effective in inducing RNase P for inhibition of gene expression and replication of human cytomegalovirus.
Yang YH; Li H; Zhou T; Kim K; Liu F
Nucleic Acids Res; 2006; 34(2):575-83. PubMed ID: 16432261
[TBL] [Abstract][Full Text] [Related]
11. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
Trang P; Liu F
Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
[TBL] [Abstract][Full Text] [Related]
12. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
Trang P; Kilani A; Kim J; Liu F
J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
[TBL] [Abstract][Full Text] [Related]
13. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
Kim K; Umamoto S; Trang P; Hai R; Liu F
RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
[TBL] [Abstract][Full Text] [Related]
14. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins.
Yang Z; Reeves M; Ye J; Trang P; Zhu L; Sheng J; Wang Y; Zen K; Wu J; Liu F
Viruses; 2015 Jun; 7(7):3345-60. PubMed ID: 26114473
[TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
Trang P; Lee J; Kilani AF; Kim J; Liu F
Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
Trang P; Zhang I; Liu F
Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
Kim K; Liu F
Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.
Lu Y; Everett RD
J Virol; 2015 Mar; 89(6):3062-75. PubMed ID: 25552717
[TBL] [Abstract][Full Text] [Related]
19. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
Kim K; Trang P; Umamoto S; Hai R; Liu F
Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
[TBL] [Abstract][Full Text] [Related]
20. Engineering of RNase P ribozyme for gene-targeting applications.
Raj SM; Liu F
Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
